Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xihuang Capsule + paclitaxel is a combination therapy that integrates traditional Chinese medicine (Xihuang Capsule) with conventional chemotherapy (paclitaxel). This combination has shown enhanced efficacy in treating various cancers, particularly breast cancer and cervical cancer. The therapy works by combining the cytotoxic effects of paclitaxel with the immunomodulatory and supportive properties of Xihuang Capsule. Clinical studies indicate this combination improves treatment response rates, enhances immune function (particularly T cell subsets), reduces adverse reactions to chemotherapy, improves quality of life, and may extend survival rates compared to paclitaxel alone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xihuang Capsule + paclitaxel.